OrthoPediatrics/$KIDS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About OrthoPediatrics
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Ticker
$KIDS
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
562
ISIN
US68752L1008
Website
OrthoPediatrics Metrics
BasicAdvanced
$529M
-
-$1.76
1.10
-
Price and volume
Market cap
$529M
Beta
1.1
52-week high
$35.99
52-week low
$19.52
Average daily volume
135K
Financial strength
Current ratio
6.187
Quick ratio
2.74
Long term debt to equity
22.964
Total debt to equity
23.01
Interest coverage (TTM)
-9.88%
Profitability
EBITDA (TTM)
-11.639
Gross margin (TTM)
72.81%
Net profit margin (TTM)
-19.15%
Operating margin (TTM)
-14.47%
Effective tax rate (TTM)
3.28%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
-4.23%
Return on equity (TTM)
-11.33%
Valuation
Price to revenue (TTM)
2.332
Price to book
1.53
Price to tangible book (TTM)
3.04
Price to free cash flow (TTM)
-13.555
Free cash flow yield (TTM)
-7.38%
Free cash flow per share (TTM)
-157.65%
Growth
Revenue change (TTM)
31.28%
Earnings per share change (TTM)
82.16%
3-year revenue growth (CAGR)
28.55%
3-year earnings per share growth (CAGR)
31.29%
What the Analysts think about OrthoPediatrics
Analyst ratings (Buy, Hold, Sell) for OrthoPediatrics stock.
Bulls say / Bears say
OrthoPediatrics reported a 40% year-over-year revenue increase to $52.67 million in Q4 2024, surpassing analyst expectations of $51.03 million. (tradingview.com)
The company launched its Enabling Technologies division, focusing on digital health and advanced technology, including the 7D Flash™ Navigation System and patient-specific cutting guides, indicating a commitment to innovation. (stocktitan.net)
Analysts from Lake Street Capital initiated coverage with a 'buy' rating and a $37.00 price target, suggesting a potential upside of approximately 75% from the current stock price. (marketbeat.com)
OrthoPediatrics' stock reached a 52-week low of $22.39, reflecting a 26.53% decline over the past year, indicating potential investor concerns. (investing.com)
The company reported a net loss of $16.07 million in Q4 2024, with an adjusted loss of $0.69 per share, missing analyst expectations of a $0.31 loss per share. (tradingview.com)
Stifel Nicolaus downgraded the stock, reducing the price target from $40.00 to $32.00, which led to a 3.5% decline in share price following the announcement. (etfdailynews.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.
OrthoPediatrics Financial Performance
Revenues and expenses
OrthoPediatrics Earnings Performance
Company profitability
OrthoPediatrics News
AllArticlesVideos
OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting
GlobeNewsWire·2 months ago
OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
GlobeNewsWire·2 months ago
OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for OrthoPediatrics stock?
OrthoPediatrics (KIDS) has a market cap of $529M as of July 01, 2025.
What is the P/E ratio for OrthoPediatrics stock?
The price to earnings (P/E) ratio for OrthoPediatrics (KIDS) stock is 0 as of July 01, 2025.
Does OrthoPediatrics stock pay dividends?
No, OrthoPediatrics (KIDS) stock does not pay dividends to its shareholders as of July 01, 2025.
When is the next OrthoPediatrics dividend payment date?
OrthoPediatrics (KIDS) stock does not pay dividends to its shareholders.
What is the beta indicator for OrthoPediatrics?
OrthoPediatrics (KIDS) has a beta rating of 1.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.